Congratulations to Daniel Barnett from the Orr lab, who has received a NRSA F31 fellowship!

Daniel Barnett from the Orr Lab was awarded an NRSA F31 predoctoral fellowship from the NIA for his proposal, “Mitochondrial complex III-derived ROS in astrocytic signaling and Alzheimer’s disease-related pathogenesis”. His research will explore how complex III ROS is a context-dependent regulator of neural signaling, neuroinflammation, and proteinopathy, which may reveal complex III ROS as a novel therapeutic target for AD and related dementias.

Weill Cornell Medicine Helen & Robert Appel Alzheimer’s Disease Research Institute 413 E. 69th St. New York, NY 10021